GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (OTCPK:CRLBF) » Definitions » Gross Profit

Cresco Labs (Cresco Labs) Gross Profit : $368.7 Mil (TTM As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Cresco Labs Gross Profit?

Cresco Labs's gross profit for the three months ended in Mar. 2024 was $92.2 Mil. Cresco Labs's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was $368.7 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Cresco Labs's gross profit for the three months ended in Mar. 2024 was $92.2 Mil. Cresco Labs's Revenue for the three months ended in Mar. 2024 was $184.3 Mil. Therefore, Cresco Labs's Gross Margin % for the quarter that ended in Mar. 2024 was 50.03%.

Cresco Labs had a gross margin of 50.03% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Cresco Labs was 49.86%. The lowest was 43.40%. And the median was 48.30%.


Cresco Labs Gross Profit Historical Data

The historical data trend for Cresco Labs's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs Gross Profit Chart

Cresco Labs Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 64.08 206.70 406.35 407.01 362.37

Cresco Labs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 85.88 86.70 93.64 96.15 92.21

Competitive Comparison of Cresco Labs's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Gross Profit distribution charts can be found below:

* The bar in red indicates where Cresco Labs's Gross Profit falls into.



Cresco Labs Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Cresco Labs's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=770.885 - 408.519
=362.4

Cresco Labs's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=184.295 - 92.083
=92.2

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $368.7 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Cresco Labs's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=92.2 / 184.295
=50.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Cresco Labs  (OTCPK:CRLBF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Cresco Labs had a gross margin of 50.03% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Cresco Labs Gross Profit Related Terms

Thank you for viewing the detailed overview of Cresco Labs's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Cresco Labs (Cresco Labs) Business Description

Traded in Other Exchanges
Address
400 W. Erie Street, Suite 110, Chicago, IL, USA, 60654
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and third-party retail stores. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.